Camilla Chong

Camilla Chong currently serves as the Chief Medical Officer at InflaRx N.V., a position held since June 2023. Prior to this role, Camilla worked at Kyowa Kirin International plc as the VP & Global Therapy Area Head for Immunology, overseeing key projects in immunology, including collaborations on Rocatinlimab and Brodalumab. Camilla's extensive experience also includes serving as Director and Chief Medical Officer at CXC Medical Consulting Ltd, Vice President & Global Medical Affairs for Respiratory at Teva Pharmaceuticals, and several senior positions at GSK, including Vice President of Dermatology Global Medical and leadership roles in Europe and Australasia. Earlier in the career, Camilla held the position of R&D Global Clinical Director at Pfizer, specializing in cardiovascular research. Camilla holds an MD from the Royal Free / University College London Hospital School of Medicine, obtained between 1985 and 1990.